Use of Serum Biomarkers to Aid Antidepressant Selection in Depressive Patients.

Hee-Ju Kang Ju-Wan Kim Wonsuk Choi Ju-Yeon Lee Sung Wan Kim Il-Seon Shin Jae-Min Kim

Published in: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (2023)

: Baseline serum status, as estimated by nine serum markers, may help clinicians determine the most appropriate antidepressant to achieve remission in the acute phase of depression.

Keyphrases

end stage renal disease
major depressive disorder
newly diagnosed
depressive symptoms
palliative care
peritoneal dialysis
patient reported outcomes
sleep quality
systemic lupus erythematosus